Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | IFIT3 |
| Upstream (Parents) |
|---|
| (<<) IFIT1 → IFIT3 |
| (<<) IFI44 → IFIT3 |
| (<<) IFIT2 → IFIT3 |
| (<<) UBE2L6 → IFIT3 |
| Downstream (Children) |
|---|
| IFIT3 → DDX58 (>>) |
| IFIT3 → JHDM1D (>>) |
| IFIT3 → ACCN3 (>>) |
| IFIT3 → IFIT1 (>>) |
| IFIT3 → PDE3A (>>) |
| IFIT3 → RSAD2 (>>) |
| IFIT3 → IFI6 (>>) |
| IFIT3 → IFI44 (>>) |
| IFIT3 → ISG15 (>>) |
| IFIT3 → HERC5 (>>) |
| IFIT3 → IFIT2 (>>) |
| IFIT3 → OAS2 (>>) |
| IFIT3 → OASL (>>) |
| IFIT3 → PTCH1 (>>) |
| IFIT3 → USP18 (>>) |
| IFIT3 → CASP1 (>>) |
| IFIT3 → EHMT2 (>>) |
| IFIT3 → SRPK3 (>>) |
| IFIT3 → STAT1 (>>) |
| IFIT3 → UBE2L6 (>>) |
